---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-008959"
form_type: "8-K"
ticker: "NTHI"
cik: "0001979414"
company_name: "NEONC TECHNOLOGIES HOLDINGS, INC."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:41:16.144962+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# NeOnc to host Nov 12 call to update on NEO100-1 trial and compassionate use data

## Summary
- Investor call on Nov 12, 2025 at 9:00 a.m. ET to present data updates from Phase 1/2a NEO100-1 trial.
- Discussion to include MRI radiographic response, progression-free survival (PFS), and overall survival (OS) trends.
- Participants include Duke and NYU Langone neuro-oncologists; management team present.
- No specific clinical results disclosed in the press release; call may provide new data.

## SEC filing metadata
- accession: 0001829126-25-008959
- form_type: 8-K
- ticker: NTHI
- cik: 0001979414
- company_name: NEONC TECHNOLOGIES HOLDINGS, INC.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1979414/000182912625008959/0001829126-25-008959-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1979414/000182912625008959/neonctechnologies_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-008959
- JSON: https://secwatch.observer/filing/0001829126-25-008959.json
- Plain text: https://secwatch.observer/filing/0001829126-25-008959.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.